A citation-based method for searching scientific literature

Shaoying Li, Pei Lin, L Jeffrey Medeiros. Expert Rev Hematol 2018
Times Cited: 11







List of co-cited articles
140 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.
Christine P Hans, Dennis D Weisenburger, Timothy C Greiner, Randy D Gascoyne, Jan Delabie, German Ott, H Konrad Müller-Hermelink, Elias Campo, Rita M Braziel, Elaine S Jaffe,[...]. Blood 2004
63

MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma.
Heike Horn, Marita Ziepert, Claudia Becher, Thomas F E Barth, Heinz-Wolfram Bernd, Alfred C Feller, Wolfram Klapper, Michael Hummel, Harald Stein, Martin-Leo Hansmann,[...]. Blood 2013
386
36

Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Nathalie A Johnson, Graham W Slack, Kerry J Savage, Joseph M Connors, Susana Ben-Neriah, Sanja Rogic, David W Scott, King L Tan, Christian Steidl, Laurie H Sehn,[...]. J Clin Oncol 2012
661
36

Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.
Bruce D Cheson, Richard I Fisher, Sally F Barrington, Franco Cavalli, Lawrence H Schwartz, Emanuele Zucca, T Andrew Lister. J Clin Oncol 2014
36

The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH.
Laura K Hilton, Jeffrey Tang, Susana Ben-Neriah, Miguel Alcaide, Aixiang Jiang, Bruno M Grande, Christopher K Rushton, Merrill Boyle, Barbara Meissner, David W Scott,[...]. Blood 2019
45
36

High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology.
David W Scott, Rebecca L King, Annette M Staiger, Susana Ben-Neriah, Aixiang Jiang, Heike Horn, Anja Mottok, Pedro Farinha, Graham W Slack, Daisuke Ennishi,[...]. Blood 2018
109
36

High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis.
Shaoying Li, Vivian L Weiss, Xuan J Wang, Parth A Desai, Shimin Hu, C Cameron Yin, Guilin Tang, Nishitha M Reddy, L Jeffrey Medeiros, Pei Lin. Am J Surg Pathol 2016
37
27


Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.
Tina Marie Green, Ken H Young, Carlo Visco, Zijun Y Xu-Monette, Attilio Orazi, Ronald S Go, Ole Nielsen, Ole V Gadeberg, Torben Mourits-Andersen, Mikael Frederiksen,[...]. J Clin Oncol 2012
482
27

Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium.
Andreas Rosenwald, Susanne Bens, Ranjana Advani, Sharon Barrans, Christiane Copie-Bergman, Mad-Helenie Elsensohn, Yaso Natkunam, Maria Calaminici, Birgitta Sander, Maryse Baia,[...]. J Clin Oncol 2019
94
27

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
Steven H Swerdlow, Elias Campo, Stefano A Pileri, Nancy Lee Harris, Harald Stein, Reiner Siebert, Ranjana Advani, Michele Ghielmini, Gilles A Salles, Andrew D Zelenetz,[...]. Blood 2016
27


High-grade B-cell lymphoma: how to diagnose and treat.
Mattia Novo, Alessia Castellino, Maura Nicolosi, Elisa Santambrogio, Francesco Vassallo, Annalisa Chiappella, Umberto Vitolo. Expert Rev Hematol 2019
9
33


Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project.
Anamarija M Perry, Jacques Diebold, Bharat N Nathwani, Kenneth A MacLennan, Hans K Müller-Hermelink, Martin Bast, Eugene Boilesen, James O Armitage, Dennis D Weisenburger. Haematologica 2016
82
27

Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.
Adam M Petrich, Mitul Gandhi, Borko Jovanovic, Jorge J Castillo, Saurabh Rajguru, David T Yang, Khushboo A Shah, Jeremy D Whyman, Frederick Lansigan, Francisco J Hernandez-Ilizaliturri,[...]. Blood 2014
298
27

Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma.
Andrés E Quesada, L Jeffrey Medeiros, Parth A Desai, Pei Lin, Jason R Westin, Huda M Hawsawi, Peng Wei, Guilin Tang, Adam C Seegmiller, Nishitha M Reddy,[...]. Mod Pathol 2017
35
18

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study.
Carlo Visco, Alexander Tzankov, Zijun Y Xu-Monette, Roberto N Miranda, Yu Chuan Tai, Yan Li, Wei-min Liu, Emanuele S G d'Amore, Yong Li, Santiago Montes-Moreno,[...]. Haematologica 2013
117
18

Poor concordance among nine immunohistochemistry classifiers of cell-of-origin for diffuse large B-cell lymphoma: implications for therapeutic strategies.
Rita Coutinho, Andrew James Clear, Andrew Owen, Andrew Wilson, Janet Matthews, Abigail Lee, Rute Alvarez, Maria Gomes da Silva, José Cabeçadas, Maria Calaminici,[...]. Clin Cancer Res 2013
92
18

MYC cytogenetic status correlates with expression and has prognostic significance in patients with MYC/BCL2 protein double-positive diffuse large B-cell lymphoma.
Xuan Julia Wang, L Jeffrey Medeiros, Pei Lin, C Cameron Yin, Shimin Hu, Mary Ann Thompson, Shaoying Li. Am J Surg Pathol 2015
43
18

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
A A Alizadeh, M B Eisen, R E Davis, C Ma, I S Lossos, A Rosenwald, J C Boldrick, H Sabet, T Tran, X Yu,[...]. Nature 2000
18

The Hans algorithm is not prognostic in patients with diffuse large B-cell lymphoma treated with R-CHOP.
Jorge J Castillo, Brady E Beltran, Moo-Kon Song, Ivana Ilic, Sirpa Leppa, Heidi Nurmi, Ritsuko Seki, Silvia Uccella, Jun-Min Li, Diana O Treaba,[...]. Leuk Res 2012
38
18

B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.
Shaoying Li, Pei Lin, Luis E Fayad, Patrick A Lennon, Roberto N Miranda, C Cameron Yin, E Lin, L Jeffrey Medeiros. Mod Pathol 2012
190
18

MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy.
Kerry J Savage, Nathalie A Johnson, Susana Ben-Neriah, Joseph M Connors, Laurie H Sehn, Pedro Farinha, Douglas E Horsman, Randy D Gascoyne. Blood 2009
463
18


Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL.
German Ott, Marita Ziepert, Wolfram Klapper, Heike Horn, Monika Szczepanowski, Heinz-Wolfram Bernd, Christoph Thorns, Alfred C Feller, Dido Lenze, Michael Hummel,[...]. Blood 2010
142
18

MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas.
Wenting Huang, L Jeffrey Medeiros, Pei Lin, Wei Wang, Guilin Tang, Joseph Khoury, Sergej Konoplev, C Cameron Yin, Jie Xu, Yasuhiro Oki,[...]. Mod Pathol 2018
23
18

Diffuse large B-cell lymphoma.
Shaoying Li, Ken H Young, L Jeffrey Medeiros. Pathology 2018
257
18

Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies.
David W Scott, Anja Mottok, Daisuke Ennishi, George W Wright, Pedro Farinha, Susana Ben-Neriah, Robert Kridel, Garrett S Barry, Christoffer Hother, Pau Abrisqueta,[...]. J Clin Oncol 2015
239
18

Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.
Annette M Staiger, Marita Ziepert, Heike Horn, David W Scott, Thomas F E Barth, Heinz-Wolfram Bernd, Alfred C Feller, Wolfram Klapper, Monika Szczepanowski, Michael Hummel,[...]. J Clin Oncol 2017
139
18

Revised response criteria for malignant lymphoma.
Bruce D Cheson, Beate Pfistner, Malik E Juweid, Randy D Gascoyne, Lena Specht, Sandra J Horning, Bertrand Coiffier, Richard I Fisher, Anton Hagenbeek, Emanuele Zucca,[...]. J Clin Oncol 2007
18

Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable.
Daniel J Landsburg, Marissa K Falkiewicz, Adam M Petrich, Benjamin A Chu, Amir Behdad, Shaoying Li, L Jeffrey Medeiros, Ryan D Cassaday, Nishitha M Reddy, Martin A Bast,[...]. Br J Haematol 2016
42
18


Stratification by MYC expression has prognostic impact in MYC translocated B-cell lymphoma-Identifies a subgroup of patients with poor outcome.
Mette Ølgod Pedersen, Anne Ortved Gang, Erik Clasen-Linde, Marie Fredslund Breinholt, Helle Knudsen, Signe Ledou Nielsen, Tim Svenstrup Poulsen, Tobias Wirenfeldt Klausen, Estrid Høgdall, Peter Nørgaard. Eur J Haematol 2019
7
28

RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and 'unclassifiable' highly aggressive B-cell lymphoma.
Gaetano Corazzelli, Ferdinando Frigeri, Filippo Russo, Chiara Frairia, Manuela Arcamone, Gennaro Esposito, Annarosaria De Chiara, Emanuela Morelli, Gaetana Capobianco, Cristina Becchimanzi,[...]. Br J Haematol 2012
52
18

Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.
Pei Lin, Timothy J Dickason, Luis E Fayad, Patrick A Lennon, Peter Hu, Mar Garcia, Mark J Routbort, Roberto Miranda, Xumei Wang, Wei Qiao,[...]. Cancer 2012
48
18

B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases.
Anamarija M Perry, David Crockett, Bhavana J Dave, Pamela Althof, Lisa Winkler, Lynette M Smith, Patricia Aoun, Wing C Chan, Kai Fu, Timothy C Greiner,[...]. Br J Haematol 2013
58
18

Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network.
Alex F Herrera, Allison Crosby-Thompson, Jonathan W Friedberg, Gregory A Abel, Myron S Czuczman, Leo I Gordon, Mark S Kaminski, Michael M Millenson, Auayporn P Nademanee, Joyce C Niland,[...]. Cancer 2014
26
18

Utility of flow cytometry of cerebrospinal fluid as a screening tool in the diagnosis of central nervous system lymphoma.
Meredith Pittman, Susan Treese, Ling Chen, John L Frater, TuDung T Nguyen, Anjum Hassan, Friederike Kreisel. Arch Pathol Lab Med 2013
21
18

Diagnostic Yield of CT-Guided Percutaneous Transthoracic Needle Biopsy for Diagnosis of Anterior Mediastinal Masses.
Milena Petranovic, Matthew D Gilman, Ashok Muniappan, Robert P Hasserjian, Subba R Digumarthy, Victorine V Muse, Amita Sharma, Jo-Anne O Shepard, Carol C Wu. AJR Am J Roentgenol 2015
38
18

Multi-institutional study of fine-needle aspiration for thyroid lymphoma.
Laura J Adhikari, Jordan P Reynolds, Paul E Wakely. J Am Soc Cytopathol 2016
7
28

Investigation of FDG-PET/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma.
Caroline Bodet-Milin, Françoise Kraeber-Bodéré, Philippe Moreau, Loïc Campion, Benoît Dupas, Steven Le Gouill. Haematologica 2008
88
18

A study to evaluate the efficacy of image-guided core biopsy in the diagnosis and management of lymphoma--results in 103 biopsies.
C Vandervelde, T Kamani, A Varghese, K Ramesar, R Grace, D C Howlett. Eur J Radiol 2008
35
18

Value of fine needle aspiration cell blocks in the diagnosis and classification of lymphoma.
Shuhong Zhang, Xiaomeng Yu, Yuanyuan Zheng, Yan Yang, Jianlan Xie, Xiaoge Zhou. Int J Clin Exp Pathol 2014
25
18

SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma.
Reina Watanabe, Naoto Tomita, Kengo Takeuchi, Seiji Sakata, Ukihide Tateishi, Masatsugu Tanaka, Hiroyuki Fujita, Yoshiaki Inayama, Yoshiaki Ishigatsubo. Leuk Lymphoma 2010
44
18

Impact of centralized diagnostic review on quality of initial staging in Hodgkin lymphoma: experience of the German Hodgkin Study Group.
Paul J Bröckelmann, Helen Goergen, Michael Fuchs, Jan Kriz, Robert Semrau, Christian Baues, Carsten Kobe, Karolin Behringer, Dennis A Eichenauer, Bastian von Tresckow,[...]. Br J Haematol 2015
5
40

CT-guided core-needle biopsy in the diagnosis of mediastinal lymphoma.
M Sklair-Levy, A Polliack, D Shaham, Y H Applbaum, S Gillis, D Ben-Yehuda, Y Sherman, E Libson. Eur Radiol 2000
47
18

The value of EUS in combination with cytological, flow cytometry, and gene rearrangement in the diagnosis of gastrointestinal lymphoma.
Liu Yu, Ke Chen, Ying Xu, Shubei Wang, Qianqian Liu, Qiao Ye, Tingjun Ye, Yunwei Sun. Hematol Oncol 2017
13
18

Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
Javeed Iqbal, Ryan Wilcox, Hina Naushad, Joseph Rohr, Tayla B Heavican, Chao Wang, Alyssa Bouska, Kai Fu, Wing C Chan, Julie M Vose. Blood Rev 2016
44
18

Simultaneous cytomorphologic and multiparametric flow cytometric analysis on lymph node samples is faster than and as valid as histopathologic study to diagnose most non-Hodgkin lymphomas.
Mercedes Colorado, M Angeles Cuadrado, Andrés Insunza, Francisco Mazorra, Olga Acinas, Arturo Iriondo. Am J Clin Pathol 2010
14
18


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.